Literature DB >> 209046

Localization of the binding site for cell attachment in the alpha1(I) chain of collagen.

H K Kleinman, E B McGoodwin, G R Martin, R J Klebe, P P Fietzek, D E Woolley.   

Abstract

Certain cells such as CHO (Chinese hamster ovary) and fibroblasts attach to a substrate of type I collagen via proteins that link the cell surface to collagen. Serum contains a glycoprotein, c-CAP (collagen cell attachment protein), that can mediate this adhesion. Previously, we established that alpha1(I)-CB7 (cyanogen bromide peptide 7), which lies within residues 552 to 822 of collagen, contains a major binding site for c-CAP(alpha1(I)-CB7 has been renumbered to account for an additional triplet recently identified at residue 613 (P. P. Fietzek and R. W. Glanville, manuscript in preparation). Now we have examined the ability of various peptides derived by proteolytic digestion of alpha1(I)-CB7 to bind to c-CAP based upon their ability to inhibit cell attachment to collagen. The binding site lies within residues 757 to 791. It is likely that this is the sole binding site in the alpha1(I) chain since cleavage of the bond between residues 775 and 776 in the alpha1(I) chain destroys cell attachment activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209046

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Adhesion, proliferation, and adipogenesis in primary rat cell cultures: effects of collagenous substrata, fibronectin, and serum.

Authors:  R L Richardson; D R Campion; G J Hausman
Journal:  Cell Tissue Res       Date:  1988-01       Impact factor: 5.249

2.  Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.

Authors:  D F Mosher; P E Schad
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

3.  Detection of type III collagen fragments in specimens of abdominal aortic aneurysms.

Authors:  T Kuga; K Esato; N Zempo; K Fujioka; K Nakamura
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  Cross-linking of fibronectin to collagenous proteins.

Authors:  D F Mosher
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 5.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

6.  Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence.

Authors:  P E Vaudaux; F A Waldvogel; J J Morgenthaler; U E Nydegger
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Carbodiimide conjugation of fibronectin on collagen basal lamina analogs enhances cellular binding domains and epithelialization.

Authors:  Katie A Bush; George D Pins
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

8.  Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin.

Authors:  P Peake; A Gooley; W J Britton
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen.

Authors:  H K Kleinman; G R Martin; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

10.  Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.